Search
for
Sort by
Research 151–180 of 875
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Chemotherapy‐induced alopecia – the urgent need for treatment options
- Hypertrichosis of the pinnae in a patient using panitumumab
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- Atlas of Geriatric Dermatology
- Familial Pure Hair–Nail Ectodermal Dysplasia in Yemen: A Father–Son Case Report with Clinical Correlation
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Androgenetic Alopecia: Therapy Update
- Table of Contents
- Anatomy and Physiology of the Skin
- Dermatological adverse events with taxane chemotherapy
- Drug-Induced Skin, Nail and Hair Disorders
- Long-Term Epilation Using the EpiLight Broad Band, Intense Pulsed Light Hair Removal System
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Hair transplantation surgery
- The Effects of Negative Pressure by External Tissue Expansion Device on Epithelial Cell Proliferation, Neo-Vascularization and Hair Growth in a Porcine Model
- Advances in Hair Restoration Surgery
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Frontal fibrosing alopecia in Asians: a retrospective clinical study
- Recurring Chemotherapy-Associated Alopecia Areata: Case Report and Literature Review
- Physiology and Medical Treatments for Alopecia
- Commentary
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Estimation of health utility values for alopecia areata
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Current and future pharmacotherapy for alopecia areata
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review